Please Wait.....
Report
Neurovascular Devices Market by Disease Pathology (Cerebral Ameurysm (Embolic coils), Ischemic Stroke (Clot retrievers, Aspiration, Microcatheters), AVM (Liquid Embolic Agents), End User (Hospitals), & Region - Global Forecast to 2028
Market Report I 2023-05-04 I 255 Pages I MarketsandMarkets
The global neurovascular devices market is projected to reach USD 5.5 Billion by 2028 from USD 3.6 Billion in 2023, at a CAGR of 8.7% during the forecast period. The increase in the demand for neurovascular devices market is driven by the increasing population proportion at a risk of developing various neurovascular diseases such as Ischemic stroke, cerebral aneurysms owing to the growing prevalence of hypertension, diabetes, and obesity. However, high cost of neuro-interventional procedures and associated products and shortage of skilled neurologists across emerging countries are likely to hamper the growth of market.
"Ischemic stroke segment accounted for the highest CAGR during the forecast period"
Based on disease pathology, the neurovascular devices market is segmented into cerebral aneurysm, ischemic strokes, carotid artery stenosis, arteriovenous malformations & fistulas, and other disease pathologies (includes cavernous malformations and moyamoya disease). The ischemic stroke segment to grow a at a higher CAGR owing to increasing incidence of ischemic stroke and increase in the mechanical thrombectomy procedures.
"The Hospitals & surgical centers segment accounted for the largest market share in the neurovascular devices market, by end user, during the forecast period"
Based on end user, the neurovascular devices market is segmented into hospitals & surgical centers, ambulatory care centers, and research laboratories and academic institutes. The hospital & surgical centers captured the largest share of neurovascular devices market during the forecast period attributed to the increasing hospitalization of target patient population, rising volume of neurovascular surgeries, and upgradation in the infrastructure of hospitals in developing nations along with the availability of technological advance neurovascular treatment devices in these settings.
"The North America segment accounted for the highest market share in the neurovascular devices market, by region, during the forecast period"
Based on the region, the global neurovascular devices market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to witness a high market share during the forecast period. This can be attributed to the factors such as strong adoption of endovascular treatment procedures for the ischemic stroke, cerebral aneurysm, and arteriovenous malformation, availability of R& D investments for development of novel neurovascular devices, strong foothold of key players in region, and favorable reimbursement policy for neurovascular treatment procedures.
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Company Type: Tier 1 (30%), Tier 2 (45%), and Tier 3 (25%)
- By Designation: C-level (20%), Director-level (20%), and Others (45%)
- By Region: North America (40%), Asia- Pacific (30%), Europe (20%), Latin America (7%) and Middle East & Africa(3%)
Prominent companies include Stryker (US), Johnson & Johnson (US), Medtronic (Ireland), Terumo Corporation (Japan), Penumbra, Inc. (US), MicroPort Scientific Corporation (China), Kaneka Corporation (Japan), BALT (France), Perflow Medical Ltd. (Israel), Phenox GmbH (Germany), Sensome (France), Evasc (Canada), Rapid Medical (Israel), Asahi Intecc Co., Ltd (Japan), Acandis GmbH (Germany), Medikit Co. Ltd. (Japan), Imperative Care (US), Lepu Medical Technology(Beijing)Co., Ltd. (China), Cerus Endovascular Inc. (USA), and Zylox-Tonbridge Medical Co., Ltd (China)
Research Coverage
This research report categorizes the neurovascular devices market by disease pathology (cerebral aneurysm, ischemic strokes, carotid artery stenosis, arteriovenous malformations & fistulas, and other disease pathologies), by end user (hospitals & surgical centers, ambulatory care centers, and research laboratories and academic institutes), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the neurovascular devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the neurovascular devices market. Competitive analysis of upcoming startups in the neurovascular devices market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall neurovascular devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (rising incidence of neurovascular diseases, increasing neurovascular procedures, availability of medical reimbursement, and expansion of healthcare infrastructure across emerging nations), restraints (high neurovascular procedural & related devices cost and shortage of skilled neurosurgeon in emerging countries ), opportunities (increase in the preference of minimally invasive neurosurgical procedures and rising R& D activities in neurovascular therapies), and challenges (stringent regulatory approval process for neurovascular treatment devices) influencing the growth of the neurovascular devices market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the neurovascular devices market.
- Market Development: Comprehensive information about lucrative markets - the report analyses the neurovascular devices market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the neurovascular devices market
- Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Stryker (US), Johnson & Johnson (US), Medtronic (Ireland), Terumo Corporation (Japan), Penumbra, Inc. (US), MicroPort Scientific Corporation (China), among others in the neurovascular devices market strategies.
1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.2.1 INCLUSIONS AND EXCLUSIONS 33
1.3 STUDY SCOPE 33
1.3.1 MARKETS COVERED 33
1.3.2 GEOGRAPHIC SCOPE 34
1.3.3 YEARS CONSIDERED 34
1.4 CURRENCY CONSIDERED 34
1.5 MARKET STAKEHOLDERS 35
1.6 RECESSION IMPACT 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
FIGURE 1 RESEARCH DESIGN 37
2.1.1 SECONDARY DATA 38
2.1.2 PRIMARY RESEARCH 39
2.1.2.1 Key data from primary sources 39
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 40
FIGURE 3 NEUROVASCULAR DEVICES MARKET: BREAKDOWN OF PRIMARIES 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 41
2.2.1 PRODUCT-BASED MARKET ESTIMATION 42
2.2.2 VOLUME-BASED MARKET ESTIMATION 42
FIGURE 5 MARKET SIZE ESTIMATION: NEUROVASCULAR DEVICES MARKET 43
2.2.3 PRIMARY RESEARCH VALIDATION 43
2.3 DATA TRIANGULATION 44
FIGURE 6 DATA TRIANGULATION METHODOLOGY 44
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 45
2.4.1 RESEARCH ASSUMPTIONS 45
2.4.2 RESEARCH LIMITATIONS 45
2.5 RECESSION IMPACT 46
TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2021-2027 (% GROWTH) 46
3 EXECUTIVE SUMMARY 47
FIGURE 7 NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023 VS. 2028 (USD MILLION) 47
FIGURE 8 HOSPITALS AND SURGICAL CENTERS SEGMENT TO CONTINUE TO DOMINATE MARKET DURING FORECAST PERIOD 48
FIGURE 9 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN NEUROVASCULAR DEVICES MARKET DURING FORECAST PERIOD 49
4 PREMIUM INSIGHTS 50
4.1 NEUROVASCULAR DEVICES MARKET OVERVIEW 50
FIGURE 10 AN INCREASE IN THE NUMBER OF DISEASES RELATED TO NEUROLOGICAL DISORDERS SUCH AS BRAIN/ CEREBRAL ANEURYSMS, STROKES, AND EPILEPSY, IS EXPECTED TO DRIVE THE MARKET GROWTH. 50
4.2 NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2023 VS. 2028 (USD MILLION) 51
FIGURE 11 CEREBRAL ANEURYSMS TO DOMINATE NEUROVASCULAR DEVICES MARKET DURING FORECAST PERIOD 51
4.3 NEUROVASCULAR DEVICES MARKET, BY REGION AND DISEASE PATHOLOGY (2022) 52
FIGURE 12 CEREBRAL ANEURYSMS SEGMENT ACCOUNTED FOR HIGHEST MARKET SHARE IN US 52
4.4 NEUROVASCULAR DEVICES MARKET, BY COUNTRY 53
FIGURE 13 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 14 NEUROVASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
5.2.1 DRIVERS 55
5.2.1.1 Rising incidence of neurovascular diseases 55
FIGURE 15 PROPORTION OF GERIATRIC TO TOTAL WORLD POPULATION, BY COUNTRY, 2020 VS. 2030 (MILLION PEOPLE) 56
5.2.1.2 Availability of medical reimbursements for neurovascular procedures 56
TABLE 2 US: REIMBURSEMENT FOR INTERVENTIONAL NEUROLOGY PROCEDURES 57
5.2.1.3 Expansion of healthcare infrastructure across emerging economies 57
5.2.1.4 Rising demand for effective neurovascular therapies 58
5.2.2 RESTRAINTS 58
5.2.2.1 Shortage of skilled neurosurgeons 58
5.2.2.2 High procedural cost of neurovascular surgeries and associated products 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Rising R&D activities for neurovascular therapies 59
5.2.3.2 Growing preference for minimally invasive neurosurgical procedures 60
5.2.4 CHALLENGES 60
5.2.4.1 Stringent regulatory approval process for medical devices 60
5.3 SUPPLY CHAIN ANALYSIS 62
FIGURE 16 NEUROVASCULAR DEVICES MARKET: SUPPLY CHAIN ANALYSIS 62
5.4 VALUE CHAIN ANALYSIS 63
FIGURE 17 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED THROUGH REGULATION & DISTRIBUTION STAGES 63
5.5 PORTER'S FIVE FORCES ANALYSIS 63
5.5.1 OVERVIEW 63
TABLE 3 NEUROVASCULAR DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS 64
5.5.2 THREAT OF NEW ENTRANTS 64
5.5.3 THREAT OF SUBSTITUTES 64
5.5.4 BARGAINING POWER OF SUPPLIERS 64
5.5.5 BARGAINING POWER OF BUYERS 65
5.5.6 INTENSITY OF COMPETITIVE RIVALRY 65
5.6 REGULATORY LANDSCAPE 65
5.6.1 NORTH AMERICA 65
5.6.1.1 US 65
TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION 66
TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 66
5.6.1.2 Canada 67
5.6.2 EUROPE 67
5.6.3 ASIA PACIFIC 67
5.6.3.1 China 67
5.6.3.2 Japan 68
5.6.3.3 India 68
5.6.3.4 South Korea 68
5.7 REIMBURSEMENT SCENARIO 69
TABLE 6 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES (2021) 69
5.8 PRICING TREND ANALYSIS 72
5.8.1 AVERAGE SELLING PRICE OF NEUROVASCULAR DEVICES, BY KEY PLAYER, 2021 (USD) 72
5.8.2 AVERAGE SELLING PRICE OF NEUROVASCULAR DEVICES, BY REGION/COUNTRY, 2021 (USD) 73
5.9 PATENT ANALYSIS 74
FIGURE 18 TOP PATENT APPLICANTS FOR ORTHOPEDIC DEVICES, JANUARY 2012-MARCH 2023 74
5.10 TRADE ANALYSIS 75
TABLE 7 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2017-2021 (USD MILLION) 75
TABLE 8 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2016-2020 (USD MILLION) 75
5.11 ECOSYSTEM MAP 76
5.12 CASE STUDY ANALYSIS 76
5.12.1 STENT-ASSISTED COILING (SAC) THERAPY FOR INTRACRANIAL ANEURYSMS 76
TABLE 9 USAGE OF INTRACRANIAL STENTS FOR TREATMENT OF BROAD-NECKED INTRACRANIAL ANEURYSMS 76
5.13 KEY CONFERENCES AND EVENTS IN 2022-2023 77
TABLE 10 NEUROVASCULAR DEVICES MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 77
FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 78
5.14 STAKEHOLDERS AND BUYING CRITERIA 79
5.14.1 KEY STAKEHOLDERS 79
FIGURE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS 79
TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATION SEGMENTS (%) 79
5.15 KEY BUYING CRITERIA 80
FIGURE 21 KEY BUYING CRITERIA FOR NEUROVASCULAR DEVICES 80
TABLE 12 KEY BUYING CRITERIA FOR NEUROVASCULAR DEVICES 80
6 NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY 81
6.1 INTRODUCTION 82
TABLE 13 NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 82
TABLE 14 NEUROVASCULAR DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION) 82
TABLE 15 NEUROVASCULAR DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION) 83
6.2 CEREBRAL ANEURYSMS 83
TABLE 16 NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 84
TABLE 17 NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY REGION, 2021-2028 (USD MILLION) 84
TABLE 18 NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY END USER, 2021-2028 (USD MILLION) 85
6.2.1 EMBOLIC COILS 85
TABLE 19 CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY REGION, 2021-2028 (USD MILLION) 86
TABLE 20 CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 86
6.2.1.1 Bare detachable coils 86
6.2.1.1.1 Significant adoption of bare detachable coils by neurosurgeons for brain aneurysm treatment to promote growth 86
TABLE 21 CEREBRAL ANEURYSMS MARKET FOR BARE DETACHABLE COILS, BY REGION, 2021-2028 (USD MILLION) 87
6.2.1.2 Coated detachable coils 87
6.2.1.2.1 High cost of coated detachable coils to limit adoption 87
TABLE 22 CEREBRAL ANEURYSMS MARKET FOR COATED DETACHABLE COILS, BY REGION, 2021-2028 (USD MILLION) 88
6.2.2 FLOW DIVERSION DEVICES 88
6.2.2.1 Rising R&D activities to develop novel flow diversion devices to promote growth 88
TABLE 23 CEREBRAL ANEURYSMS MARKET FOR FLOW DIVERSION DEVICES, BY REGION, 2021-2028 (USD MILLION) 89
6.2.3 INTRACRANIAL STENTS 89
6.2.3.1 Increased efficacy of stent-assisted coiling for treatment of wide-necked intracranial aneurysms to boost adoption 89
TABLE 24 CEREBRAL ANEURYSMS MARKET FOR INTRACRANIAL STENTS, BY REGION, 2021-2028 (USD MILLION) 89
6.2.4 MICROCATHETERS 90
6.2.4.1 Growing number of neurovascular procedures and favorable reimbursement scenarios to boost demand 90
TABLE 25 CEREBRAL ANEURYSMS MARKET FOR MICROCATHETERS, BY REGION, 2021-2028 (USD MILLION) 90
6.2.5 GUIDEWIRES 90
6.2.5.1 Growing utilization of nitinol guidewires for cerebral aneurysm procedures to boost growth 90
TABLE 26 CEREBRAL ANEURYSMS MARKET FOR GUIDEWIRES, BY REGION, 2021-2028 (USD MILLION) 91
6.3 ISCHEMIC STROKES 91
TABLE 27 NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKE, BY REGION, 2021-2028 (USD MILLION) 92
TABLE 28 NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKE, BY TYPE 2021-2028 (USD MILLION) 92
TABLE 29 NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKE, BY END USER, 2021-2028 (USD MILLION 93
6.3.1 CLOT RETRIEVER DEVICES 93
6.3.1.1 Growing number of clinical trials for development of novel clot retriever stents to drive market 93
TABLE 30 ISCHEMIC STROKES MARKET FOR CLOT RETRIEVER DEVICES, BY REGION, 2021-2028 (USD MILLION) 94
6.3.2 SUCTION & ASPIRATION DEVICES 94
6.3.2.1 Rapid commercialization of technologically advanced aspiration devices for ischemic stroke treatment to support market 94
TABLE 31 ISCHEMIC STROKES MARKET FOR SUCTION & ASPIRATION DEVICES, BY REGION, 2021-2028 (USD MILLION) 95
6.3.3 VASCULAR SNARES 95
6.3.3.1 Limited procedural benefits in stroke treatment to limit adoption of vascular snares 95
TABLE 32 ISCHEMIC STROKES MARKET FOR VASCULAR SNARES, BY REGION, 2021-2028 (USD MILLION) 95
6.3.4 MICROCATHETERS 96
6.3.4.1 High demand for minimally invasive treatment in ischemic strokes to boost adoption of microcatheters 96
TABLE 33 ISCHEMIC STROKES MARKET FOR MICROCATHETERS, BY REGION, 2021-2028 (USD MILLION) 96
6.3.5 MICROGUIDEWIRES 96
6.3.5.1 Increasing innovations in guidewires to promote growth 96
TABLE 34 ISCHEMIC STROKES MARKET FOR MICROGUIDEWIRES, BY REGION, 2021-2028 (USD MILLION) 97
6.3.6 BALLOON CATHETERS 97
6.3.6.1 Growing recognition of benefits associated with balloon catheters to bolster demand 97
TABLE 35 ISCHEMIC STROKES MARKET FOR BALLOON CATHETERS, BY REGION, 2021-2028 (USD MILLION) 98
6.4 CAROTID ARTERY STENOSIS 98
TABLE 36 NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS CAROTID ARTERY STENOSIS, BY REGION, 2021-2028 (USD MILLION) 98
TABLE 37 NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 99
TABLE 38 NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY END USER, 2021-2028 (USD MILLION) 99
6.4.1 CAROTID ARTERY STENTS 99
6.4.1.1 Growing adoption of carotid artery stents for carotid intervention procedures to support growth 99
TABLE 39 CAROTID ARTERY STENOSIS MARKET FOR CAROTID ARTERY STENTS, BY REGION, 2021-2028 (USD MILLION) 100
6.4.2 EMBOLIC PROTECTION DEVICES 101
6.4.2.1 Growing utilization of distal filters during carotid intervention procedures to promote growth 101
TABLE 40 CAROTID ARTERY STENOSIS MARKET FOR EMBOLIC PROTECTION DEVICES, BY REGION, 2021-2028 (USD MILLION) 101
6.4.3 BALLOON CATHETERS 102
6.4.3.1 Growing preference for balloon catheters to improve efficacy of carotid intervention procedures to augment growth 102
TABLE 41 CAROTID ARTERY STENOSIS MARKET FOR BALLOON CATHETERS, BY REGION, 2021-2028 (USD MILLION) 102
6.5 ARTERIOVENOUS MALFORMATION & FISTULAS 102
TABLE 42 NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY REGION, 2021-2028 (USD MILLION) 103
TABLE 43 NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 103
TABLE 44 NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATION & FISTULAS, BY END USER, 2021-2028 (USD MILLION) 103
6.5.1 LIQUID EMBOLIC AGENTS 104
6.5.1.1 Development of novel liquid embolic agents offering high embolization of arteriovenous fistulas to support growth 104
TABLE 45 ARTERIOVENOUS MALFORMATION & FISTULAS MARKET FOR LIQUID EMBOLIC AGENTS, BY REGION, 2021-2028 (USD MILLION) 104
6.5.2 OCCLUSION BALLOON CATHETERS 104
6.5.2.1 Growing utilization of balloon catheters for AVM treatment to support growth 104
TABLE 46 ARTERIOVENOUS MALFORMATION & FISTULAS MARKET FOR OCCLUSION BALLOON CATHETERS, BY REGION, 2021-2028 (USD MILLION) 105
6.5.3 MICROCATHETERS 105
6.5.3.1 Improved compatibility of microcatheters with embolic agents to boost demand 105
TABLE 47 ARTERIOVENOUS MALFORMATION & FISTULAS MARKET FOR MICROCATHETERS, BY REGION, 2021-2028 (USD MILLION) 105
6.6 OTHER DISEASE PATHOLOGIES 106
TABLE 48 NEUROVASCULAR DEVICES MARKET FOR OTHER DISEASE PATHOLOGIES, BY REGION, 2021-2028 (USD MILLION) 106
TABLE 49 NEUROVASCULAR DEVICES MARKET FOR OTHER DISEASE PATHOLOGIES, BY END USER, 2021-2028 (USD MILLION) 106
7 NEUROVASCULAR DEVICES MARKET, BY END USER 107
7.1 INTRODUCTION 108
TABLE 50 NEUROVASCULAR DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION) 108
7.2 HOSPITALS AND SURGICAL CENTERS 108
7.2.1 INCREASING VOLUME OF NEUROVASCULAR PROCEDURES DUE TO AVAILABILITY OF ADVANCED EQUIPMENT TO DRIVE MARKET 108
TABLE 51 NEUROVASCULAR DEVICES MARKET FOR HOSPITALS AND SURGICAL CENTERS, BY REGION, 2021-2028 (USD MILLION) 109
7.3 AMBULATORY CARE CENTERS 109
7.3.1 OPERATIONAL AND ECONOMIC BENEFITS OFFERED BY ACCS TO DRIVE MARKET 109
TABLE 52 NEUROVASCULAR DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2021-2028 (USD MILLION) 110
7.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 110
7.4.1 INCREASING COLLABORATIONS FOR DEVELOPMENT OF TECHNOLOGICALLY ADVANCED NEUROVASCULAR DEVICES TO SUPPORT MARKET GROWTH 110
TABLE 53 NEUROVASCULAR DEVICES MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2021-2028 (USD MILLION) 111
8 NEUROVASCULAR DEVICES MARKET, BY REGION 112
8.1 INTRODUCTION 113
TABLE 54 NEUROVASCULAR DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION) 113
8.2 NORTH AMERICA 113
8.2.1 NORTH AMERICA: RECESSION IMPACT 114
FIGURE 22 NEUROVASCULAR DEVICES MARKET: NORTH AMERICA SNAPSHOT 115
TABLE 55 NORTH AMERICA: NEUROVASCULAR DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 115
TABLE 56 NORTH AMERICA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 116
TABLE 57 NORTH AMERICA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 116
TABLE 58 NORTH AMERICA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 117
TABLE 59 NORTH AMERICA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 117
TABLE 60 NORTH AMERICA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 117
TABLE 61 NORTH AMERICA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 118
TABLE 62 NORTH AMERICA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION) 118
8.2.2 US 118
8.2.2.1 Presence of established neurovascular device manufacturers to drive market 118
TABLE 63 US: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 119
TABLE 64 US: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 119
TABLE 65 US: EMBOLIC COILS MARKET, BY TYPE, 2021-2028 (USD MILLION) 120
TABLE 66 US: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 120
TABLE 67 US: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 120
TABLE 68 US: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 121
8.2.3 CANADA 121
8.2.3.1 Large target pool for ischemic stroke patients to drive market 121
TABLE 69 CANADA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 122
TABLE 70 CANADA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 122
TABLE 71 CANADA: EMBOLIC COILS MARKET, BY TYPE, 2021-2028 (USD MILLION) 122
TABLE 72 CANADA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 123
TABLE 73 CANADA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 123
TABLE 74 CANADA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 123
8.3 EUROPE 124
8.3.1 EUROPE: RECESSION IMPACT 124
TABLE 75 EUROPE: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 125
TABLE 76 EUROPE: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 125
TABLE 77 EUROPE: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 126
TABLE 78 EUROPE: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 126
TABLE 79 EUROPE: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 126
TABLE 80 EUROPE: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 127
TABLE 81 EUROPE: NEUROVASCULAR DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION) 127
8.3.2 GERMANY 127
8.3.2.1 Increasing adoption of endovascular coils and stents to drive market 127
TABLE 82 GERMANY: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 128
TABLE 83 GERMANY: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 128
TABLE 84 GERMANY: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 129
TABLE 85 GERMANY: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 129
TABLE 86 GERMANY: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 129
TABLE 87 GERMANY: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 130
8.3.3 FRANCE 130
8.3.3.1 Growing preference for minimally invasive neurovascular procedures to drive market 130
TABLE 88 FRANCE: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 131
TABLE 89 FRANCE: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 131
TABLE 90 FRANCE: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 132
TABLE 91 FRANCE: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKE, BY TYPE, 2021-2028 (USD MILLION) 132
TABLE 92 FRANCE: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 132
TABLE 93 FRANCE: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 133
8.3.4 UK 133
8.3.4.1 Rising government initiatives to increase accessibility of neurovascular procedures to drive market 133
TABLE 94 UK: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 134
TABLE 95 UK: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 134
TABLE 96 UK: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 135
TABLE 97 UK: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 135
TABLE 98 UK: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 135
TABLE 99 UK: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 136
8.3.5 ITALY 136
8.3.5.1 Increasing thrombectomy treatment rates to drive demand for neurovascular devices 136
TABLE 100 ITALY: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 137
TABLE 101 ITALY: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 137
TABLE 102 ITALY: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 138
TABLE 103 ITALY: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 138
TABLE 104 ITALY: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 138
TABLE 105 ITALY: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 139
8.3.6 SPAIN 139
8.3.6.1 Rising number of clinical trials for interventional neurovascular procedures to support market growth 139
TABLE 106 SPAIN: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 140
TABLE 107 SPAIN: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 140
TABLE 108 SPAIN: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 141
TABLE 109 SPAIN: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 141
TABLE 110 SPAIN: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 141
TABLE 111 SPAIN: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 142
8.3.7 REST OF EUROPE 142
TABLE 112 REST OF EUROPE: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 143
TABLE 113 REST OF EUROPE: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 143
TABLE 114 REST OF EUROPE: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 144
TABLE 115 REST OF EUROPE: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 144
TABLE 116 REST OF EUROPE: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 144
TABLE 117 REST OF EUROPE: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 145
8.4 ASIA PACIFIC 145
8.4.1 ASIA PACIFIC: RECESSION IMPACT 146
TABLE 118 ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 146
TABLE 119 ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 147
TABLE 120 ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 147
TABLE 121 ASIA PACIFIC: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 148
TABLE 122 ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 148
TABLE 123 ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 148
TABLE 124 ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 149
TABLE 125 ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION) 149
FIGURE 23 NEUROVASCULAR DEVICES MARKET: ASIA PACIFIC SNAPSHOT 150
8.4.2 JAPAN 151
8.4.2.1 Favorable reimbursement policy for adoption of neurovascular procedures to drive market 151
TABLE 126 JAPAN: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 151
TABLE 127 JAPAN: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 152
TABLE 128 JAPAN: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 152
TABLE 129 JAPAN: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 152
TABLE 130 JAPAN: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 153
TABLE 131 JAPAN: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 153
8.4.3 CHINA 153
8.4.3.1 Robust presence of neurovascular device manufacturers to drive market 153
TABLE 132 CHINA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 154
TABLE 133 CHINA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 154
TABLE 134 CHINA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 155
TABLE 135 CHINA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 155
TABLE 136 CHINA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 155
TABLE 137 CHINA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 156
8.4.4 INDIA 156
8.4.4.1 Supportive government initiatives to drive uptake for neurovascular devices 156
TABLE 138 INDIA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 157
TABLE 139 INDIA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 157
TABLE 140 INDIA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 158
TABLE 141 INDIA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 158
TABLE 142 INDIA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 158
TABLE 143 INDIA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 159
8.4.5 AUSTRALIA 159
8.4.5.1 Rising incidence of cerebrovascular disease to drive market 159
TABLE 144 AUSTRALIA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 160
TABLE 145 AUSTRALIA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 160
TABLE 146 AUSTRALIA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 161
TABLE 147 AUSTRALIA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 161
TABLE 148 AUSTRALIA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 161
TABLE 149 AUSTRALIA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 162
8.4.6 SOUTH KOREA 162
8.4.6.1 Health insurance coverage for neurovascular procedures to support market growth 162
TABLE 150 SOUTH KOREA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 163
TABLE 151 SOUTH KOREA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 163
TABLE 152 SOUTH KOREA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 164
TABLE 153 SOUTH KOREA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 164
TABLE 154 SOUTH KOREA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 164
TABLE 155 SOUTH KOREA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 165
8.4.7 REST OF ASIA PACIFIC 165
TABLE 156 REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 165
TABLE 157 REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 166
TABLE 158 REST OF ASIA PACIFIC: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 166
TABLE 159 REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 166
TABLE 160 REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 167
TABLE 161 REST OF ASIA PACIFIC: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 167
8.5 LATIN AMERICA 167
8.5.1 LATIN AMERICA: RECESSION IMPACT 167
TABLE 162 LATIN AMERICA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 168
TABLE 163 LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 168
TABLE 164 LATIN AMERICA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 169
TABLE 165 LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 169
TABLE 166 LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 169
TABLE 167 LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 170
TABLE 168 LATIN AMERICA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION) 170
8.5.2 BRAZIL 170
8.5.2.1 Increasing awareness initiatives on stroke symptoms to drive market 170
TABLE 169 BRAZIL: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 171
TABLE 170 BRAZIL: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 171
TABLE 171 BRAZIL: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 172
TABLE 172 BRAZIL: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 172
TABLE 173 BRAZIL: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 172
TABLE 174 BRAZIL: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 173
8.5.3 MEXICO 173
8.5.3.1 Increasing incidence of neurovascular diseases to support market growth 173
TABLE 175 MEXICO: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 174
TABLE 176 MEXICO: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 174
TABLE 177 MEXICO: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 175
TABLE 178 MEXICO: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 175
TABLE 179 MEXICO: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 175
TABLE 180 MEXICO: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 176
8.5.4 REST OF LATIN AMERICA 176
TABLE 181 REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 176
TABLE 182 REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 177
TABLE 183 REST OF LATIN AMERICA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 177
TABLE 184 REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 177
TABLE 185 REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 178
TABLE 186 REST OF LATIN AMERICA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS AND FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 178
8.6 MIDDLE EAST & AFRICA 178
8.6.1 SHORTAGE OF NEUROSURGEONS AND POOR HEALTHCARE COVERAGE TO RESTRAIN MARKET GROWTH 178
8.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 179
TABLE 187 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR CEREBRAL ANEURYSMS, BY TYPE, 2021-2028 (USD MILLION) 179
TABLE 188 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2021-2028 (USD MILLION) 180
TABLE 189 MIDDLE EAST & AFRICA: CEREBRAL ANEURYSMS MARKET FOR EMBOLIC COILS, BY TYPE, 2021-2028 (USD MILLION) 180
TABLE 190 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR ISCHEMIC STROKES, BY TYPE, 2021-2028 (USD MILLION) 181
TABLE 191 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR CAROTID ARTERY STENOSIS, BY TYPE, 2021-2028 (USD MILLION) 181
TABLE 192 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET FOR ARTERIOVENOUS MALFORMATIONS & FISTULAS, BY TYPE, 2021-2028 (USD MILLION) 181
TABLE 193 MIDDLE EAST & AFRICA: NEUROVASCULAR DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION) 182
9 COMPETITIVE LANDSCAPE 183
9.1 INTRODUCTION 183
9.1.1 STRATEGIES ADOPTED BY KEY PLAYERS 183
FIGURE 24 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS (2019?2023) 184
9.2 REVENUE SHARE ANALYSIS 185
FIGURE 25 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN NEUROVASCULAR DEVICES MARKET 185
9.3 MARKET SHARE ANALYSIS 185
FIGURE 26 NEUROVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER (2022) 186
9.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2022) 187
9.4.1 STARS 187
9.4.2 EMERGING LEADERS 187
9.4.3 PERVASIVE PLAYERS 187
9.4.4 PARTICIPANTS 187
FIGURE 27 NEUROVASCULAR DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR KEY PLAYERS (2021) 188
9.5 COMPETITIVE LEADERSHIP MAPPING: STARTUPS/SME EVALUATION QUADRANT (2022) 189
9.5.1 PROGRESSIVE COMPANIES 189
9.5.2 RESPONSIVE COMPANIES 189
9.5.3 DYNAMIC COMPANIES 189
9.5.4 STARTING BLOCKS 189
FIGURE 28 NEUROVASCULAR DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/STARTUPS (2022) 190
9.6 NEUROVASCULAR DEVICES MARKET: FOOTPRINT ANALYSIS OF LEADING PLAYERS 191
TABLE 194 COMPANY FOOTPRINT ANALYSIS 191
TABLE 195 PRODUCT FOOTPRINT 192
TABLE 196 REGIONAL FOOTPRINT 193
9.6.1 PRODUCT LAUNCHES & APPROVALS 194
TABLE 197 NEUROVASCULAR DEVICES MARKET: KEY PRODUCT LAUNCHES & APPROVALS (JANUARY 2019-MARCH 2023) 194
9.6.2 DEALS 194
TABLE 198 NEUROVASCULAR DEVICES MARKET: KEY DEALS (JANUARY 2019-MARCH 2023) 194
9.6.3 OTHER DEVELOPMENTS 195
TABLE 199 NEUROVASCULAR DEVICES MARKET: OTHER DEVELOPMENTS (JANUARY 2019-MARCH 2023) 195
10 COMPANY PROFILES 196
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
10.1 KEY PLAYERS 196
10.1.1 STRYKER 196
TABLE 200 STRYKER: BUSINESS OVERVIEW 196
FIGURE 29 STRYKER: COMPANY SNAPSHOT (2022) 197
10.1.2 MEDTRONIC 201
TABLE 201 MEDTRONIC: BUSINESS OVERVIEW 201
FIGURE 30 MEDTRONIC: COMPANY SNAPSHOT (2022) 202
10.1.3 JOHNSON & JOHNSON 206
TABLE 202 JOHNSON & JOHNSON: BUSINESS OVERVIEW 206
FIGURE 31 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022) 207
10.1.4 TERUMO CORPORATION 210
TABLE 203 TERUMO CORPORATION: BUSINESS OVERVIEW 210
FIGURE 32 TERUMO CORPORATION: COMPANY SNAPSHOT (2021) 211
10.1.5 PENUMBRA, INC. 214
TABLE 204 PENUMBRA, INC.: BUSINESS OVERVIEW 214
FIGURE 33 PENUMBRA, INC.: COMPANY SNAPSHOT (2022) 215
10.1.6 MICROPORT SCIENTIFIC CORPORATION 217
TABLE 205 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 217
FIGURE 34 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 218
10.1.7 BALT 221
TABLE 206 BALT: BUSINESS OVERVIEW 221
10.1.8 KANEKA CORPORATION 224
TABLE 207 KANEKA CORPORATION: BUSINESS OVERVIEW 224
FIGURE 35 KANEKA CORPORATION: COMPANY SNAPSHOT (2022) 225
TABLE 208 PRODUCT LAUNCHES 226
10.1.9 PHENOX GMBH 227
TABLE 209 PHENOX GMBH: BUSINESS OVERVIEW 227
10.1.10 ASAHI INTECC CO., LTD 229
TABLE 210 ASAHI INTECC CO., LTD.: BUSINESS OVERVIEW 229
FIGURE 36 ASAHI INTECC: COMPANY SNAPSHOT (2022) 229
10.1.11 PERFLOW MEDICAL LTD. 231
TABLE 211 PERFLOW MEDICAL LTD.: BUSINESS OVERVIEW 231
10.1.12 RAPID MEDICAL 233
TABLE 212 RAPID MEDICAL: BUSINESS OVERVIEW 233
10.1.13 CERUS ENDOVASCULAR INC. 235
TABLE 213 CERUS ENDOVASCULAR INC.: BUSINESS OVERVIEW 235
10.1.14 ACANDIS GMBH 237
TABLE 214 ACANDIS GMBH: BUSINESS OVERVIEW 237
TABLE 215 ACANDIS GMBH: PRODUCTS OFFERED 237
10.1.15 EVASC 239
TABLE 216 EVASC: BUSINESS OVERVIEW 239
10.1.16 SENSOME 240
TABLE 217 SENSOME: BUSINESS OVERVIEW 240
10.1.17 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 241
TABLE 218 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: BUSINESS OVERVIEW 241
FIGURE 37 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD: COMPANY SNAPSHOT (2021) 242
10.1.18 IMPERATIVE CARE 244
TABLE 219 IMPERATIVE CARE: BUSINESS OVERVIEW 244
TABLE 220 IMPERATIVE CARE: PRODUCT LAUNCHES AND APPROVALS 245
10.1.19 MEDIKIT CO., LTD. 246
TABLE 221 MEDIKIT CO., LTD.: BUSINESS OVERVIEW 246
10.1.20 ZYLOX-TONBRIDGE MEDICAL CO., LTD. 247
TABLE 222 ZYLOX-TONBRIDGE MEDICAL CO., LTD.: BUSINESS OVERVIEW 247
FIGURE 38 ZYLOX-TONBRIDGE MEDICAL CO., LTD.: COMPANY SNAPSHOT (2021) 248
TABLE 223 ZYLOX-TONBRIDGE MEDICAL CO., LTD.: PRODUCT LAUNCHES AND APPROVALS 249
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
10.2 OTHER PLAYERS 250
10.2.1 SILK ROAD MEDICAL, INC. 250
10.2.2 ARTIO MEDICAL, INC. 250
10.2.3 IVASCULAR 251
10.2.4 OXFORDENDOVASCULAR 251
10.2.5 NEUROVASC TECHNOLOGIES, INC. 252
11 APPENDIX 253
11.1 DISCUSSION GUIDE 253
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 257
11.3 CUSTOMIZATION OPTIONS 259
11.4 RELATED REPORTS 260
11.5 AUTHOR DETAILS 261
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security